Acrux Limited (ASX:ACR)
Australia · Delayed Price · Currency is AUD 0.0150
0.00 (0.00%)
Jan 30, 2026, 10:51 AM AEST
Acrux Market Cap
Acrux has a market cap or net worth of 6.16 million as of January 30, 2026. Its market cap has decreased by -52.92% in one year.
Market Cap
6.16M
Enterprise Value
8.93M
Revenue
1.19M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.02
Market Cap Chart
Since September 29, 2004, Acrux's market cap has decreased from 90.77M to 6.16M, a decrease of -93.21%. That is a compound annual growth rate of -11.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 29, 2026 | 6.16M | - |
| Dec 31, 2025 | 6.16M | -53.60% |
| Dec 31, 2024 | 13.27M | 4.16% |
| Dec 29, 2023 | 12.74M | -36.43% |
| Dec 30, 2022 | 20.05M | -29.33% |
| Dec 31, 2021 | 28.37M | -18.52% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Immuron | 12.69M |
| AdAlta | 11.48M |
| Chimeric Therapeutics | 11.05M |
| Patrys | 10.22M |
| Biotron | 9.64M |
| Bio-Gene Technology | 9.46M |
| Invex Therapeutics | 9.02M |
| Zelira Therapeutics | 8.09M |